Detalhe da pesquisa
1.
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.
J Immunol
; 208(12): 2847-2855, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595309
2.
The role of therapy in the outcome of patients with myelofibrosis.
Cancer
; 129(18): 2828-2835, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243913
3.
Relevant Clinical Factors in Patients with Myelofibrosis on Ruxolitinib for 5 or More Years.
Acta Haematol
; 146(6): 522-529, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699357
4.
Improved survival of patients with myelofibrosis in the last decade: Single-center experience.
Cancer
; 128(8): 1658-1665, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35077575
5.
Ibrutinib and Venetoclax for First-Line Treatment of CLL.
N Engl J Med
; 380(22): 2095-2103, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31141631
6.
TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysis.
Am J Hematol
; 97(8): 1005-1012, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567779
7.
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
Clin Infect Dis
; 72(10): 1755-1763, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236406
8.
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission.
Cancer
; 127(11): 1894-1900, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449377
9.
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia.
Cancer
; 127(17): 3113-3124, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914911
10.
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia.
Br J Haematol
; 194(1): 61-68, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973230
11.
Myelofibrosis osteoclasts are clonal and functionally impaired.
Blood
; 133(21): 2320-2324, 2019 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745304
12.
Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy.
Blood
; 134(22): 1951-1959, 2019 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537528
13.
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia.
Blood
; 133(10): 1011-1019, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30530801
14.
Altered T-cell subset repertoire affects treatment outcome of patients with myelofibrosis.
Haematologica
; 106(9): 2384-2396, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732359
15.
A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
Haematologica
; 106(8): 2121-2130, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853292
16.
Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
Am J Hematol
; 96(8): 914-924, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901324
17.
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage.
J Immunol
; 203(11): 3078-3085, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31645416
18.
Prognostic value of blasts in peripheral blood in myelofibrosis in the ruxolitinib era.
Cancer
; 126(19): 4322-4331, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32697338
19.
Long-term results of frontline dasatinib in chronic myeloid leukemia.
Cancer
; 126(7): 1502-1511, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999839
20.
Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia.
Cancer
; 126(7): 1448-1459, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999850